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Postoperative hemorrhage is one of the most severe complications after pancreaticoduodenectomy. While
detection of bleeding from adjacent arteries via conventional angiography and treatment with endovascular arterial
coil embolization has been well established, to date no reports of percutaneous therapy for mesoportal
hemorrhage have been published. This article describes an unusual case of delayed post-pancreaticoduodenectomy
hemorrhage detected on a fluoroscopic drain check and treated with percutaneous transhepatic covered stent
placement.Background
Post-pancreaticoduodenectomy hemorrhage represents
a rare, but one of the most serious complications in
pancreatic surgery associated with high mortality rate
[1,2]. This dreaded complication is often preceded by
sentinel bleed and tends to occur as a result of postop-
erative pancreatic fistula causing vascular erosion and
bleeding [1-5]. While arterial embolization has been
shown to be an effective first line treatment in delayed
post-pancreaticoduodenectomy hemorrhage (DPH) in
multiple studies, up to 50% of patients require a second
laparotomy for non-localized bleeding site [2-4]. We re-
port a case of DPH in a patient with post-operative course
complicated by pancreatic fistula that presented with a
sentinel bleed. The mesenteric angiogram was negative
and hemorrhage source was incidentally detected on a
fluoroscopic drain check and was subsequently treated
with percutaneous transhepatic covered stent placement.
Case presentation
The patient is a 77-year-old female who underwent pan-
creaticoduodenectomy for adenocarcinoma of the ampulla
of Vater. Tumor adherence to the superior mesenteric-
portal vein confluence was identified during surgery and
required a lateral wall resection with primary repair to* Correspondence: hectorferral@gmail.com
2Department of Radiology, NorthShore University HealthSystem, 2650 Ridge
Avenue, Evanston, Illinois 60201, USA
Full list of author information is available at the end of the article
© 2014 Ginsburg et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.achieve complete tumor extirpation. The post-surgical
inpatient course was complicated by the development of a
pancreatic fistula, which was properly controlled by a
Jackson-Pratt (JP) drain placed during surgery. The
patient presented with bleeding on postoperative day
18 with a sudden onset frank bloody output (415 cm3/
24 hours) from her JP drain consistent with a sentinel
bleed. Hemoglobin levels dropped from 9.8 to 7.8 g/dl
in a period of 24 hours. She remained hemodynamically
stable and was initially managed by transfusion of one
unit of packed red blood cells and intravenous fluids.
A mesenteric angiogram with possible embolization
was requested, along with a JP drain check and ex-
change. Selective catheterization and angiography of the
celiac and superior mesenteric arteries demonstrated no
evidence for arterial source of bleeding or pseudoaneur-
ysm. The mesenteric angiogram was carried to the venous
phase and no active bleeding was detected. The JP drain
was then injected with a diluted nonionic iodinated
contrast agent (Figure 1A). This showed expected opacifi-
cation of the postoperative bed and no evidence of
fistulous communication to the bowel. The JP was then
exchanged over wire for a 12-Fr all-purpose drainage
catheter (Flexima APD, Boston Scientific, Natick, MA,
USA) and contrast was injected again to confirm a
good catheter position. This catheter injection demon-
strated opacification of the portal vein (Figure 1B).al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Fluoroscopic drain contrast injection. (A) Jackson-Pratt (JP) surgical drain injection showing expected opacification of the postoperative
bed with no evidence of fistula. (B) Post-exchange of JP drain for an all-purpose drainage catheter; opacification of the portal vein at the superior
mesenteric vein and portal vein confluence is observed after all-purpose drainage catheter injection.
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cutaneous transhepatic stent placement. A percutaneous
transhepatic puncture of a right portal venous branch
was performed with a 22-gauge needle (Neff Percutan-
eous Access Set; Cook Medical, Bloomington, IN, USA)
under sonographic and fluoroscopic guidance. The nee-
dle was exchanged for a 4-Fr coaxial dilator followed by
placement of a 7-Fr vascular sheath (Boston Scientific)
over a 0.035-inch Amplatz guidewire (Boston Scientific).
Direct main portography demonstrated no evidence of
active extravasation; however, a subtle narrowing area and
wall irregularity of the superior mesenteric vein (SMV) at
its confluence with the main portal vein was noted
(Figure 2A) corresponding to the origin of portal vein
opacification, and the site of suspected bleeding, based
on the drain check (Figure 2B). A direct portogramFigure 2 Percutaneous transhepatic portogram (A) Percutaneous tran
main portal vein with no evidence of active extravasation. Slight narro
main portal vein is noted. (B) A 7-Fr vascular sheath within the main porta
contour irregularity and narrowing of the SMV at the site of suspected bleewas then performed using a 5-Fr calibrated sizing
catheter to determine the optimal size and location for
the planned endovascular stent graft placement. A
polytetrafluoroethylene-covered balloon expandable
iCAST stent (Atrium Medical Corporation, Hudson,
NH, USA) was deployed under fluoroscopic guidance
into the SMV (stent diameter 8 mm, length 38 mm) to
seal the suspected bleeding site (Figure 3A). The 12-Fr
all-purpose drainage catheter was then again injected
to confirm successful seal of the portal vein and SMV
junction fistula with the postoperative cavity (Figure 3B).
The percutaneous transhepatic tract was embolized using
a single 4 mm × 14 cm Nester coil (Cook Medical). Pa-
tient bleeding resolved and the patient was discharged
home on postoperative day 32 and 2 weeks after percutan-
eous stent-graft placement.shepatic portogram showing 5-Fr vascular sheath within the
wing of the superior mesenteric vein (SMV) at its confluence with the
l vein and calibrated sizing catheter in the SMV demonstrating wall
ding based on the drain check.
Figure 3 Post stent placement percutaneous transhepatic portogram and fluoroscopic drain contrast injection (A) Post-stent
deployment portogram shows covered balloon expandable iCAST stent in superior mesenteric vein (SMV) with interval resolution of
vessel wall contour irregularity and narrowing. (B) A 12-Fr all-purpose drainage catheter injection confirming successful seal of the fistula
between the SMV and the postoperative cavity.
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after SMV stent-graft placement demonstrated a widely
patent stent-graft and no residual fluid collection. The
pancreatic fistula resolved within 4 weeks after stent
placement and final abscessogram and drain removal
was performed 4 weeks after stenting. The patient was
seen again in clinic 7 months after intervention and




(DPH) is a life threatening complication seen in less
than 5% of patients, but associated with a mortality
rate as high as 60% [1,2]. The international consensus
classification established by the International Study Group
for Pancreatic Surgery categorize post-pancreatectomy
hemorrhage based on timing, severity and site of bleeding
[1]. While early hemorrhage, defined as bleeding within
the first 24 hours after surgery, is most commonly a result
of surgical technical failure, delayed hemorrhage, defined
as any bleeding after 24 hours and often days to weeks
later, is thought to be caused by erosion of skeletonized
visceral vessels as a result of postoperative pancreatic
fistula or abscess [1,3]. The term “sentinel bleed” refers to
an isolated episode of bleeding, usually from an abdominal
drain, implying structural vascular defect and requiring
immediate evaluation due to possible impending major
hemorrhage [3-5].
Multiple studies have advocated arterial embolization
as a primary intervention for extraluminal DPH with
the rationale of avoiding significant morbidity and mor-
tality associated with a technically difficult reoperation
[3-6]. The reported overall success rate for angiographichemostasis of extraluminal DPH has ranged between 50%
and 80% [4-6]. The postulated causes of false-negative an-
giographies include the intermittent character of bleeding
episodes and venous bleeding, which is difficult to identify
after an arterial injection [6]. To the best of our knowledge
this is the first described detection of mesoportal venous
bleeding via drain check as well as percutaneous transhe-
patic treatment of DPH due to a bleeding SMV.
Insertion of self-expandable stents in the portal vein or
SMV has been used only rarely; however, the few reports
in the literature are encouraging. Hellman and colleagues
[7] used self-expandable stents through a stenotic SMV
caused by midgut carcinoid disease, with four out of seven
patients experiencing improvement of abdominal symp-
toms and one bleeding complication related to liver punc-
ture that required a second intervention. Percutaneous
transhepatic portal vein stent placement was deemed to
be a safe and effective treatment for portal vein stenosis
caused by both a benign entity or by tumor recurrence
after curative surgery for pancreatic or biliary neoplasm
[8-10]. However, Kim and collegaues reported three major
complications (septicemia, liver abscess, and acute portal
venous thrombosis) out of a total of 18 patients after
successful stent placement [10].
In our case, the stent was placed successfully without
procedural complications, resolving the patient’s DPH
and avoiding reoperation. While venous bleeding is a
rare cause of DPH, with the exact incidence unknown, it
is important to consider it when the mesenteric angio-
gram is negative. In retrospect, it can be argued that
triple-phase computed tomography should have been
performed as it could have showed the cause, approxi-
mate site and nature of the bleeding [3]. However, it
would not have eliminated the need for a mesenteric
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the exact site of the venous bleeding.
Conclusion
In conclusion, DPH is an important and potentially lethal
complication. When the mesenteric angiogram is negative,
a venous source for the bleed should be considered and
investigated. Our experience shows that endovascular
treatment with percutaneous transhepatic stenting is safe
and may be an effective option in management of post-
surgical mesenteric venous bleeding.
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